Tigermed

/
/
Tigermed
CRDMO
Tigermed is a leading publicly listed full-service CRO (Contract Research Organization) in China (Stock Codes: 300347 / 03347.HK), providing one-stop R&D services to the global pharmaceutical and medical device industries. With operations across Asia-Pacific, Europe, and the United States, Tigermed leverages a rigorous quality system and an international professional team to deliver end-to-end solutions—from drug discovery to post-marketing studies—for innovative products.
Project Introduction
Complex CRO contract settlement and global operations require a system-level solution. This project automates three billing models, integrates contract change management with multi-system data flows, and enables deep finance–operations integration, real-time intercompany settlement, and accurate project cost tracking—enhancing the efficiency of global multi-center clinical trial management.
Solutions
CRO Sales Contract Management Contract Change Management Implementation of Three Complex Billing Models Multi-System Integration Refined Revenue Recognition
Project Benefits
Granular Contract Management Automated Intercompany Settlement Accurate Project Cost Accounting Integrated Finance & Business Data